Merck to pause investments in Russia, will supply essential medicines

Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly/File Photo

March 16 (Reuters) – Drugmaker Merck and Co (MRK.N) said on Wednesday it would supply life-saving medicines and vaccines to Russia, but not make further investments in the country.

The company does not have any research or production facilities in Russia, a company’s spokesperson said.

Reporting by Bhanvi Satija in Bengaluru; Editing by Anil D’Silva

Our Standards: The Thomson Reuters Trust Principles.